theragenomics: biomarkers

thasso has prepared for you the overview table “theragenomic biomarkers” in context of their medications, indications, and pertinent FDA drug label sections (which may point to the affected patient groups).  The basis for this product is the list of accepted biomarkers as published by the FDA. Drugs are linked to the according drug labels accessible in Drugs@FDA.

  • Please note that in this table, the active pharmacological ingredient (API) is listed; brand names may vary considerably, that is trade names for drugs approved outside the US may differ from those found within the US, as may the names of generics, both within and outside the US. In case of doubt, searching for the API in the first place would be a good idea.
  • Please note also that you may download detailed version of the Table of Pharmacogenomic Biomarkers in Drug Labeling with Labeling Text, with complete PGX-related labelling text sections excerpted from the complete drug labels.

 

Last update: December 11, 2020